ZA200200299B - Thiophene A2A receptor agonists. - Google Patents

Thiophene A2A receptor agonists.

Info

Publication number
ZA200200299B
ZA200200299B ZA200200299A ZA200200299A ZA200200299B ZA 200200299 B ZA200200299 B ZA 200200299B ZA 200200299 A ZA200200299 A ZA 200200299A ZA 200200299 A ZA200200299 A ZA 200200299A ZA 200200299 B ZA200200299 B ZA 200200299B
Authority
ZA
South Africa
Prior art keywords
thiophene
receptor agonists
disclosed
purposes
alkylthienyl
Prior art date
Application number
ZA200200299A
Other languages
English (en)
Inventor
Jeffrey A Zablocki
Elfatih O Elzein
Venkata P Palle
Original Assignee
Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutics Inc filed Critical Therapeutics Inc
Publication of ZA200200299B publication Critical patent/ZA200200299B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200200299A 1999-06-22 2002-01-14 Thiophene A2A receptor agonists. ZA200200299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22

Publications (1)

Publication Number Publication Date
ZA200200299B true ZA200200299B (en) 2003-08-27

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200299A ZA200200299B (en) 1999-06-22 2002-01-14 Thiophene A2A receptor agonists.

Country Status (19)

Country Link
US (1) US6440948B1 (es)
EP (1) EP1194441B1 (es)
JP (1) JP2003502434A (es)
KR (1) KR100463694B1 (es)
CN (1) CN1166677C (es)
AT (1) ATE252595T1 (es)
AU (1) AU768530B2 (es)
BR (1) BR0011853A (es)
CA (1) CA2373410C (es)
DE (1) DE60006116T2 (es)
ES (1) ES2206259T3 (es)
HK (1) HK1048821B (es)
IL (2) IL147194A0 (es)
MX (1) MXPA01013323A (es)
NO (1) NO20016242L (es)
NZ (1) NZ516336A (es)
TR (1) TR200200617T2 (es)
WO (1) WO2000078776A2 (es)
ZA (1) ZA200200299B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347512C (en) * 1998-10-16 2005-12-06 Pfizer Inc. Adenine derivatives
CN1279984C (zh) 2002-02-15 2006-10-18 Cv医药有限公司 用于医用装置的聚合物涂层
TWI346109B (en) * 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
PT1758596E (pt) * 2004-05-26 2010-06-23 Inotek Pharmaceuticals Corp Derivados de purina como agonistas do receptor de adenosina a1 e processos para a sua utilização
RU2007114887A (ru) * 2004-09-20 2008-10-27 Инотек Фармасьютикалз Корпорейшн (Us) Производные пурина и способы их применения
CN101321460A (zh) * 2005-11-30 2008-12-10 伊诺泰克制药公司 嘌呤衍生物及其用法
EP2523669B1 (en) 2010-01-11 2016-12-07 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
PL2807178T3 (pl) 2012-01-26 2017-12-29 Inotek Pharmaceuticals Corporation Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania
MX2015013234A (es) 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Formulaciones oftalmicas.
EP3568153A4 (en) 2017-01-13 2020-09-16 Tobishi Pharmaceutical Co., Ltd. NEUTROPHILIC ACTIVATION REGULATOR

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (es) * 1972-05-15 1974-02-01
JPS5518625B2 (es) * 1973-07-26 1980-05-20
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
DK0508687T3 (da) * 1991-04-06 1996-02-05 Astra Pharma Prod ATP-analoger

Also Published As

Publication number Publication date
BR0011853A (pt) 2002-04-30
EP1194441A2 (en) 2002-04-10
CN1166677C (zh) 2004-09-15
IL147194A0 (en) 2002-08-14
US6440948B1 (en) 2002-08-27
KR20020028912A (ko) 2002-04-17
NO20016242L (no) 2002-02-21
ES2206259T3 (es) 2004-05-16
NZ516336A (en) 2004-01-30
DE60006116D1 (de) 2003-11-27
CA2373410A1 (en) 2000-12-28
AU5625100A (en) 2001-01-09
MXPA01013323A (es) 2003-10-15
TR200200617T2 (tr) 2002-06-21
WO2000078776A2 (en) 2000-12-28
WO2000078776A3 (en) 2001-06-28
HK1048821B (zh) 2005-02-25
EP1194441B1 (en) 2003-10-22
AU768530B2 (en) 2003-12-18
JP2003502434A (ja) 2003-01-21
HK1048821A1 (en) 2003-04-17
CA2373410C (en) 2006-08-29
KR100463694B1 (ko) 2004-12-29
CN1364170A (zh) 2002-08-14
NO20016242D0 (no) 2001-12-19
ATE252595T1 (de) 2003-11-15
DE60006116T2 (de) 2004-07-08
IL147194A (en) 2007-08-19

Similar Documents

Publication Publication Date Title
CA2377746A1 (en) N-pyrazole a2a receptor agonists
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
IL147194A0 (en) Thiophene a2a receptor agonists
MA26699A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2375385A1 (en) Propargyl phenyl ether a2a receptor agonists
MY148937A (en) Medicaments with hm74a receptor activity
DK0975595T3 (da) Kokainanaloger
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
DE3752123D1 (de) Derivate des physiologisch aktiven mittels k-252
TR200201001T2 (tr) Pürin türevleri
JO2503B1 (en) Benzathiazole derivatives
MXPA03001344A (es) Derivados de piridina 2,4-substituidos.
JPH11509181A (ja) 水溶性アデノシンキナーゼ阻害剤
IL137266A0 (en) Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
DK0476066T3 (da) Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
PL335016A1 (en) Novel polymorph of 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl]-1-phtalazine acetic acid monohydrate, method of obtaining same, method of obtaining anhydrous 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl-1-phtalazine acetic acid, therapeutic methods, pharmaceutic agent, application of said polymorph in production of such pharmaceutic agent and method of obtaining the last mentioned one
CN100480255C (zh) A1腺苷受体的部分和完全激动剂
CA2304821A1 (en) Osteoblast-specific mitogens and drugs containing such compounds
ATE260118T1 (de) Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten